Treatment of seasonal allergic rhinitis in patients ≥6 years old and perennial allergic rhinitis in patients ≥12 years old. Omnaris is an alcohol-free, hypotonic suspension formulation of the ...
Researchers say people using a common allergy nasal spray, azelastine, were 69% less likely to contract COVID-19.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results